查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1282918

臨床試驗管理軟件市場-全球市場規模、份額、趨勢分析、機會、預測報告，2019-2029，按產品；按交付模式；按部署模式；按最終用途；

Clinical Trial Management Software Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Delivery Mode ; By Deployment Mode ; By End Use ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球臨床試驗管理軟件 (CTMS) 市場將在 2029 年擴大 2.5 倍以上，超過 26 億美元

由於臨床試驗的複雜性不斷增加、海量數據的生成以及 CTMS 中人工智能等現代技術的採用，全球臨床試驗管理軟件 (CTMS) 市場正在獲得越來越多的關注。

戰略諮詢和市場研究領導者 BlueWeave Consulting 最近估計，2022 年全球臨床試驗管理軟件 (CTMS) 市場價值將達到 10.3278 億美元。 在2023-2029年預測期內，全球臨床試驗管理軟件（CTMS）市場規模預計將以14.55%的複合年增長率增長，到2029年達到26.5643億美元。 臨床試驗管理軟件（CTMS）市場的關鍵增長因素包括產學界合作的加強、臨床試驗數量的增加、醫療保健技術的開拓以及政府對研究試驗的補貼增加。 此外，慢性病發病率上升等變量與臨床試驗管理系統 (CTMS) 數量的增加有關。

本報告的詳細分析提供了有關增長潛力、未來趨勢和全球臨床試驗管理軟件 (CTMS) 市場的信息。 它還涵蓋了推動市場總規模預測的因素。 該報告致力於提供全球臨床試驗管理軟件（CTMS）市場的最新技術發展和行業見解，幫助決策者做出明智的戰略決策。 它還分析了市場的增長動力、挑戰和競爭動態。

內容

第一章研究框架

第 2 章執行摘要

第 3 章全球臨床試驗管理軟件 (CTMS) 市場洞察

  • 行業價值鏈分析
  • DROC 分析
    • 增長動力
      • 需要有效管理臨床試驗數據和工作流程
      • 臨床試驗的複雜性和生成的大量數據
      • 在CTMS中引入人工智能等創新技術
    • 制約因素
      • 安裝和維護成本高
      • 數據隱私和安□□全問題
    • 機會
      • 個性化醫療需求不斷增長
      • 對罕見疾病的關注日益增加
    • 任務
      • 確保基於雲的臨床試驗管理軟件 (CTMS) 系統中的數據隱私和安□□全
  • 技術進步/最新發展
  • 監管框架
  • 波特五力分析

第 4 章全球臨床試驗管理軟件 (CTMS) 市場概述

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品
      • 軟件
      • 服務
    • 通過交付
      • 網絡託管
      • 本地
      • 基於雲
    • 按部署模式
      • 公司
      • 現場
    • 按最終用途
      • 醫藥
      • 醫療器械製造商
      • 合同研究組織
      • 其他
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第 5 章：北美臨床試驗管理軟件 (CTMS) 市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品
    • 通過交付
    • 按部署模式
    • 按最終用途
    • 按國家/地區
      • 美國
      • 加拿大

第 6 章：歐洲臨床試驗管理軟件 (CTMS) 市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品
    • 通過交付
    • 按部署模式
    • 按最終用途
    • 按國家/地區
      • 德國
      • 英國
      • 意大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 歐洲其他地區

第七章亞太臨床試驗管理軟件 (CTMS) 市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品
    • 通過交付
    • 按部署模式
    • 按最終用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和新西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區的其他國家/地區

第 8 章：拉丁美洲的臨床試驗管理軟件 (CTMS) 市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品
    • 通過交付
    • 按部署模式
    • 按最終用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其餘拉丁美洲地區

第 9 章中東和非洲臨床試驗管理軟件 (CTMS) 市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品
    • 通過交付
    • 按部署模式
    • 按最終用途
    • 按國家/地區
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 卡塔爾
      • 科威特
      • 南非
      • 尼日利亞
      • 阿爾及利亞
      • 多邊環境協定的其餘部分

第 10 章競爭格局

  • 主要公司及其產品列表
  • 2022 年全球臨床試驗管理軟件 (CTMS) 市場份額分析
  • 通過運行參數進行競爭基準測試
  • 重大戰略發展（合併、收購、合作夥伴關係等）

第 11 章 COVID-19 對全球臨床試驗管理軟件 (CTMS) 市場的影響

第十二章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭對手、聯繫地址、戰略展望、SWOT 分析）

  • Oracle Corporation
  • Medidata Solutions（a Dassault Systemes Company）
  • Parexel International Corporation
  • BioClinica, Inc.
  • PRA Health Sciences, Inc.
  • ArisGlobal LLC
  • Veeva Systems Inc.
  • MedNet Solutions, Inc.
  • Forte Research Systems, Inc.
  • eClinForce, Inc.
  • DSG, Inc.
  • Data MATRIX Corp.
  • Merge Healthcare Incorporated
  • DATATRAK International, Inc.
  • MasterControl, Inc.
  • Other Prominent Players

第 13 章關鍵戰略建議

第 14 章研究方法

  • 定性研究
    • 初級和次級研究
  • 定量研究
  • 市場細分和數據三角測量
    • 二次調查
    • 初步調查
  • 主要調查受訪者按地區細分
  • 假設和限制
簡介目錄
Product Code: BWC23421

Global Clinical Trial Management Software (CTMS) Market Size Zooming More Than 2.5X to Cross USD 2.6 Billion by 2029

The global clinical trial management software (CTMS) market is gaining traction because of the increasing complexity of clinical trials and the huge amount of data generated and adoption of modern technologies, such as artificial intelligence, in CTMS.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global clinical trial management software (CTMS) market size at USD 1,032.78 million in 2022. During the forecast period between 2023 and 2029, the global clinical trial management software (CTMS) market size is projected to grow at an impressive CAGR of 14.55% reaching a value of USD 2,656.43 million by 2029. Major growth factors for the global clinical trial management software (CTMS) market include the rise in industry-academic partnerships, the rise in clinical trials, the development of healthcare technology, and the expansion of government funding for research trials. Additionally, variables like the rising frequency of chronic diseases have been linked to the growth in the number of clinical trial management systems (CTMS).

Global Clinical Trial Management Software (CTMS) Market - Overview:

An enterprise software system called a clinical trial management system (CTMS) is used to coordinate and monitor clinical research operations within a facility. This system serves various purposes including giving easy access to a summary of a study's development with ongoing and current reporting, enabling research supervisors to schedule assignments and activities, assign roles, measure progress, arranging all of the data and papers pertinent to the study. A CTMS is used by research sites, site networks, health systems, academic medical centers, and cancer centers to centralize data on procedures, participants, staff, finances, and billing, among other things.

Global Clinical Trial Management Software (CTMS) Market - By Deployment Mode:

Based on deployment Mode, the global clinical trial management system (CTMS) market is segmented into enterprise and on-site. Enterprise deployment holds the larger share of the global clinical trial management system (CTMS) market. The segment growth is mainly attributed to its versatility according to the needs of the researchers and other end users. The capabilities of the clinical trial administration system include documents, spreadsheets, payments, contacts, and others. Enterprise-based clinical trial management software provides SMEs and large enterprises with a range of scaling options.

Impact of COVID-19 on the Global Clinical Trial Management Software (CTMS) Market

The global clinical trial management system (CTMS) market witnessed robust growth over the COVID-19 outbreak period. According to a report published on the National Center for Biotechnology Information, the management of clinical studies was adversely affected by the COVID-19 pandemic, which could jeopardize the validity of the data and cause patient safety concerns. It increased the need for efficient management systems, which not only help with the management of ongoing and delayed clinical trial data but also efficiently manage and improve access to clinical trials on the novel corona virus vaccine development.

Competitive Landscape:

Major players operating in the global clinical trial management system (CTMS) market include: Oracle Corporation, Medidata Solutions (a Dassault Systemes Company), Parexel International Corporation, BioClinica, Inc., PRA Health Sciences, Inc., ArisGlobal LLC, Veeva Systems Inc., MedNet Solutions, Inc., Forte Research Systems, Inc., eClinForce, Inc., DSG, Inc., Data MATRIX Corp., Merge Healthcare Incorporated, DATATRAK International, Inc., and MasterControl, Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Clinical Trial Management Software (CTMS) market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Clinical Trial Management Software (CTMS) market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Clinical Trial Management Software (CTMS) Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Need for efficient management of trial data and workflows
      • 3.2.1.2. Increasing complexity of clinical trials and the huge amount of data generated
      • 3.2.1.3. The adoption of innovative technologies such as artificial intelligence in CTMS
    • 3.2.2. Restraints
      • 3.2.2.1. High implementation and maintenance costs
      • 3.2.2.2. Data privacy and security concerns
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing demand for personalized medicine
      • 3.2.3.2. Increasing focus on rare diseases
    • 3.2.4. Challenges
      • 3.2.4.1. Ensuring data privacy and security in cloud-based Clinical Trial Management Software (CTMS) systems
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Clinical Trial Management Software (CTMS) Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Software
      • 4.2.1.2. Services
    • 4.2.2. By Delivery
      • 4.2.2.1. Web-hosted
      • 4.2.2.2. On-premises
      • 4.2.2.3. Cloud-based
    • 4.2.3. By Deployment Mode
      • 4.2.3.1. Enterprise
      • 4.2.3.2. On-site
    • 4.2.4. By End Use
      • 4.2.4.1. Pharma
      • 4.2.4.2. Medical Device Manufacturers
      • 4.2.4.3. CROs
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Clinical Trial Management Software (CTMS) Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Delivery
    • 5.2.3. By Deployment Mode
    • 5.2.4. By End Use
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Product
      • 5.2.5.1.2. By Delivery
      • 5.2.5.1.3. By Deployment Mode
      • 5.2.5.1.4. By End Use
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Product
      • 5.2.5.2.2. By Delivery
      • 5.2.5.2.3. By Deployment Mode
      • 5.2.5.2.4. By End Use

6. Europe Clinical Trial Management Software (CTMS) Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Delivery
    • 6.2.3. By Deployment Mode
    • 6.2.4. By End Use
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Product
      • 6.2.5.1.2. By Delivery
      • 6.2.5.1.3. By Deployment Mode
      • 6.2.5.1.4. By End Use
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Product
      • 6.2.5.2.2. By Delivery
      • 6.2.5.2.3. By Deployment Mode
      • 6.2.5.2.4. By End Use
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Product
      • 6.2.5.3.2. By Delivery
      • 6.2.5.3.3. By Deployment Mode
      • 6.2.5.3.4. By End Use
      • 6.2.5.4. France
      • 6.2.5.4.1. By Product
      • 6.2.5.4.2. By Delivery
      • 6.2.5.4.3. By Deployment Mode
      • 6.2.5.4.4. By End Use
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Product
      • 6.2.5.5.2. By Delivery
      • 6.2.5.5.3. By Deployment Mode
      • 6.2.5.5.4. By End Use
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Product
      • 6.2.5.6.2. By Delivery
      • 6.2.5.6.3. By Deployment Mode
      • 6.2.5.6.4. By End Use
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Product
      • 6.2.5.7.2. By Delivery
      • 6.2.5.7.3. By Deployment Mode
      • 6.2.5.7.4. By End Use
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Product
      • 6.2.5.8.2. By Delivery
      • 6.2.5.8.3. By Deployment Mode
      • 6.2.5.8.4. By End Use
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Product
      • 6.2.5.9.2. By Delivery
      • 6.2.5.9.3. By Deployment Mode
      • 6.2.5.9.4. By End Use

7. Asia-Pacific Clinical Trial Management Software (CTMS) Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Delivery
    • 7.2.3. By Deployment Mode
    • 7.2.4. By End Use
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Product
      • 7.2.5.1.2. By Delivery
      • 7.2.5.1.3. By Deployment Mode
      • 7.2.5.1.4. By End Use
      • 7.2.5.2. India
      • 7.2.5.2.1. By Product
      • 7.2.5.2.2. By Delivery
      • 7.2.5.2.3. By Deployment Mode
      • 7.2.5.2.4. By End Use
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Product
      • 7.2.5.3.2. By Delivery
      • 7.2.5.3.3. By Deployment Mode
      • 7.2.5.3.4. By End Use
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Product
      • 7.2.5.4.2. By Delivery
      • 7.2.5.4.3. By Deployment Mode
      • 7.2.5.4.4. By End Use
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Product
      • 7.2.5.5.2. By Delivery
      • 7.2.5.5.3. By Deployment Mode
      • 7.2.5.5.4. By End Use
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Product
      • 7.2.5.6.2. By Delivery
      • 7.2.5.6.3. By Deployment Mode
      • 7.2.5.6.4. By End Use
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Product
      • 7.2.5.7.2. By Delivery
      • 7.2.5.7.3. By Deployment Mode
      • 7.2.5.7.4. By End Use
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Product
      • 7.2.5.8.2. By Delivery
      • 7.2.5.8.3. By Deployment Mode
      • 7.2.5.8.4. By End Use
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Product
      • 7.2.5.9.2. By Delivery
      • 7.2.5.9.3. By Deployment Mode
      • 7.2.5.9.4. By End Use
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Product
      • 7.2.5.10.2. By Delivery
      • 7.2.5.10.3. By Deployment Mode
      • 7.2.5.10.4. By End Use

8. Latin America Clinical Trial Management Software (CTMS) Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Delivery
    • 8.2.3. By Deployment Mode
    • 8.2.4. By End Use
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Product
      • 8.2.5.1.2. By Delivery
      • 8.2.5.1.3. By Deployment Mode
      • 8.2.5.1.4. By End Use
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Product
      • 8.2.5.2.2. By Delivery
      • 8.2.5.2.3. By Deployment Mode
      • 8.2.5.2.4. By End Use
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Product
      • 8.2.5.3.2. By Delivery
      • 8.2.5.3.3. By Deployment Mode
      • 8.2.5.3.4. By End Use
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Product
      • 8.2.5.4.2. By Delivery
      • 8.2.5.4.3. By Deployment Mode
      • 8.2.5.4.4. By End Use
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Product
      • 8.2.5.5.2. By Delivery
      • 8.2.5.5.3. By Deployment Mode
      • 8.2.5.5.4. By End Use

9. Middle East & Africa Clinical Trial Management Software (CTMS) Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Delivery
    • 9.2.3. By Deployment Mode
    • 9.2.4. By End Use
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Product
      • 9.2.5.1.2. By Delivery
      • 9.2.5.1.3. By Deployment Mode
      • 9.2.5.1.4. By End Use
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Product
      • 9.2.5.2.2. By Delivery
      • 9.2.5.2.3. By Deployment Mode
      • 9.2.5.2.4. By End Use
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Product
      • 9.2.5.3.2. By Delivery
      • 9.2.5.3.3. By Deployment Mode
      • 9.2.5.3.4. By End Use
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Product
      • 9.2.5.4.2. By Delivery
      • 9.2.5.4.3. By Deployment Mode
      • 9.2.5.4.4. By End Use
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Product
      • 9.2.5.5.2. By Delivery
      • 9.2.5.5.3. By Deployment Mode
      • 9.2.5.5.4. By End Use
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Product
      • 9.2.5.6.2. By Delivery
      • 9.2.5.6.3. By Deployment Mode
      • 9.2.5.6.4. By End Use
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Product
      • 9.2.5.7.2. By Delivery
      • 9.2.5.7.3. By Deployment Mode
      • 9.2.5.7.4. By End Use
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Product
      • 9.2.5.8.2. By Delivery
      • 9.2.5.8.3. By Deployment Mode
      • 9.2.5.8.4. By End Use

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Clinical Trial Management Software (CTMS) Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Clinical Trial Management Software (CTMS) Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Oracle Corporation
  • 12.2. Medidata Solutions (a Dassault Systemes Company)
  • 12.3. Parexel International Corporation
  • 12.4. BioClinica, Inc.
  • 12.5. PRA Health Sciences, Inc.
  • 12.6. ArisGlobal LLC
  • 12.7. Veeva Systems Inc.
  • 12.8. MedNet Solutions, Inc.
  • 12.9. Forte Research Systems, Inc.
  • 12.10. eClinForce, Inc.
  • 12.11. DSG, Inc.
  • 12.12. Data MATRIX Corp.
  • 12.13. Merge Healthcare Incorporated
  • 12.14. DATATRAK International, Inc.
  • 12.15. MasterControl, Inc.
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations